Publicaciones en colaboración con investigadores/as de Hospital Miguel Servet (11)

2020

  1. COVID-19 and fragility hip fracture. Joint recommendations of the Spanish Society of Osteoporotic Fractures and the Spanish Society of Geriatrics and Gerontology

    Revista Espanola de Geriatria y Gerontologia, Vol. 55, Núm. 5, pp. 300-308

2019

  1. Registro Nacional de Fracturas de Cadera (RNFC): resultados del primer año y comparación con otros registros y estudios multicéntricos españoles

    Revista espanola de salud publica, Vol. 93

  2. The impact of hip fracture on health-related quality of life and activities of daily living: the SPARE-HIP prospective cohort study

    Archives of Osteoporosis, Vol. 14, Núm. 1

2018

  1. In-hospital care, complications, and 4-month mortality following a hip or proximal femur fracture: the Spanish registry of osteoporotic femur fractures prospective cohort study

    Archives of Osteoporosis, Vol. 13, Núm. 1

2017

  1. Cost-effectiveness analysis of therapeutic options for chronic hepatitis C genotype 3 infected patients

    Expert Review of Gastroenterology and Hepatology, Vol. 11, Núm. 1, pp. 85-93

2016

  1. Cost-effectiveness analysis of simeprevir with daclatasvir for non-cirrhotic genotype-1b-naïve patients plus chronic hepatitis C

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 16, Núm. 2, pp. 285-294

  2. Cost-effectiveness analysis of sofosbuvir-simeprevir regimens for chronic hepatitis C genotype 1 patients with advanced fibrosis

    Medicina Clinica, Vol. 146, Núm. 2, pp. 61-64

  3. Sofosbuvir plus simeprevir for the treatment of genotype 1 chronic hepatitis C: a review of evidence

    Expert Review of Gastroenterology and Hepatology, Vol. 10, Núm. 11, pp. 1289-1303

2015

  1. Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C

    Gut, Vol. 64, Núm. 8, pp. 1277-1288

2014

  1. Cost-effectiveness of protease inhibitor based regimens for chronic hepatitis C: A systematic review of published literature

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 14, Núm. 3, pp. 387-402

2013

  1. Los costes del ictus en España según su etiología. El protocolo del estudio CONOCES

    Neurologia, Vol. 28, Núm. 6, pp. 332-339